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Background: Diabetes mellitus is accompanied by chronic and dangerous microvascular 
changes affecting most body systems, especially the eye, leading to diabetic retinopathy. Dia-
betic retinopathy without appropriate management is emerging as one of the leading causes 
of blindness. Therefore, it is necessary to improve the early diagnosis of diabetic retinopathy, 
reduce the risk of blindness, and identify relevant risk factors.
Methods: This descriptive study was designed to estimate the prevalence of retinopathy and its 
staging in diabetic patients attending the diabetes clinic at King Fahd Hospital in Al-Madinah 
  Al-Munawarah, Kingdom of Saudi Arabia, from 2008 to 2010. Patients completed a   questionnaire, 
underwent a full medical assessment carried out by the treating clinicians, and were examined 
for evidence of diabetic retinopathy using standard ophthalmic outpatient instruments.
Results: In total, 690 randomly selected diabetic patients of mean age 46.10 ± 11.85 (range 
16–88) years were included, comprising 395 men (57.2%) of mean age 46.50 ± 11.31 years and 
295 women (42.8%) of mean age 45.55 ± 12.53 years. The mean duration of diabetes mellitus 
was 11.91 ± 7.92 years in the women and 14.42 ± 8.20 years in the men, and the mean total 
duration of known diabetes mellitus was 13.35 ± 8.17 years. Glycated hemoglobin was higher 
in men (8.53% ± 1.81%) than in women (7.73% ± 1.84%), and this difference was statistically 
significant (P # 0.0001). Of the 690 diabetic patients, 249 (36.1%) had retinopathy. Mild 
  nonproliferative diabetic retinopathy was present in 13.6% of patients, being of moderate grade 
in 8% and of severe grade in 8.1%. A further 6.4% had proliferative diabetic retinopathy.
Conclusion: Regular screening to detect diabetic retinopathy is strongly recommended because 
early detection has the best chance of preventing retinal complications.
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Introduction
Diabetes mellitus is a major public health problem worldwide. Worryingly, the World 
Health Organization1,2 has estimated that the number of adults with diabetes worldwide 
will increase from 135 million in 1995 to 300 million in 2025. Recent studies have 
shown a significant increase in the prevalence of diabetes mellitus.3 The prevalence 
was about 23.7% during 2004 in Saudi Arabia,4 but by 2011 there has been a significant 
increase to 30%, with a rate of 34.1% in men and 27.6% in women.5
Diabetic retinopathy is a serious complication of the chronic microvascular changes 
that occur in most body systems in diabetics. Untreated diabetic retinopathy has chronic 
complications and is emerging as an important cause of blindness. Progression of 
retinopathy is gradual, advancing from mild abnormalities characterized by increased 
vascular permeability to moderate-severe nonproliferative diabetic retinopathy, through 
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to proliferative diabetic retinopathy characterized by growth 
of new blood vessels on the retina and posterior surface of 
the vitreous.6
The pathophysiological mechanisms leading to develop-
ment of diabetic retinopathy are indeed complex and remain 
unclear, but several theories have been postulated to explain 
the typical course and history of the disease. Multiple inter-
active mechanisms may come into play, causing cellular 
damage and adaptive changes which lead to the development 
of this devastating complication of diabetes.7
Diabetic retinopathy is a leading cause of visual impair-
ment in people with diabetes8 aged 20–64 years,9 and more 
than 77% of patients who survive for over 20 years with 
diabetes mellitus are affected by the condition.10 The main 
risk factors involved in the development of microvascular 
and macrovascular complications of diabetes include a long 
disease duration,11,12 inadequate control of serum glucose 
levels,12–16 hypertension,11,12 dyslipidemia, smoking,17,18 
gender,13,19 and pregnancy.20,21 Genetic factors also seem to 
play a role in predisposition to microvascular and macro-
vascular disease.22,23 Diabetic retinopathy occurs in approxi-
mately 84.5% of patients with a known disease duration of 
15 years.13,24 The prevalence of retinopathy in type 2 diabetes 
is 12%.8,25,26 During the first two decades of the disease, nearly 
all patients with type 1 diabetes and up to 60% of patients 
with type 2 diabetes develop retinopathy.27 In this study, our 
aims were to estimate the prevalence of retinopathy among 
diabetics and to investigate the associations between risk 
factors and stages of diabetic retinopathy.
Materials and methods
The study was part of a general survey carried out to assess 
the prevalence of retinopathy and blindness as one of the 
complications of diabetes mellitus among patients with the 
disease in Al-Madinah Al-Munawarah District, Kingdom of 
Saudi Arabia, in 2008–2010.
We obtained ethics committee approval, and informed 
consent was taken from the 690 diabetic men and women 
recruited for this study. The participants were randomly 
selected, with 57.2% being male and 42.8% being female, 
giving a gender ratio of 1.33:1, with a total mean age of 
46.1 ± 11.85 years (Table 1).
Risk factors investigated included demographic and clini-
cal parameters. The demographic parameters were age and 
gender, and the clinical parameters were glycated hemoglo-
bin (HbA1C) levels and coexistence of hypertension, using 
the World Health Organization definition of hypertension, 
ie, systolic blood pressure $130 mmHg and/or a diastolic 
blood pressure $90 mmHg, or requirement for ongoing 
treatment with antihypertensive drugs.
The patients were interviewed by clinicians at the dia-
betic patient center and hospital outpatient clinic to collect 
information about type of diabetes and years since diagnosis 
of the disease (treated as an ordinal variable [0, 0–5 years; 
1, 5–10 years; 2, 10–15 years; 3, 15–20 years; 4, .20 years]). 
Data on compliance with treatment as assessed by   doctors, 
associated complications, and comorbidity were also 
  collected. Blood pressure was measured by a nurse early 
in the morning in the sitting position prior to drawing 
blood samples, using a standard mercury sphygmomano-
meter. Height was measured without shoes, and weight was 
recorded while wearing indoor clothing. Body mass index 
(BMI, weight in kg divided by height in meters squared) 
was calculated. The World Health Organization classifica-
tion of BMI was used to estimate the degree of obesity.28 
Obesity was assessed, and classified as overweight (BMI 
25.0–29.9 kg/m2), obese (30.0–39.9 kg/m2), or morbidly 
obese (40.0 kg/m2).29
Blood samples were collected from both controls and 
patients for a series of laboratory investigations using standard 
protocols for estimation of fasting and postprandial blood 
glucose, serum total cholesterol, triglycerides, high-density 
and low-density lipoprotein cholesterol, serum creatinine, 
and HbA1C (DiaSTAT Hemoglobin A1c program, Bio-Rad 
Laboratories, Hercules, CA). The estimated normal range for 
HbA1C in nondiabetics is 4.4%–6.4%; a value ,7% was con-
sidered as good glycemic control and .7 was considered as 
poor control.30,31 A blood cholesterol level ,5.18 mmol/L was 
considered normal, 5.18–6.18 mmol/L as borderline high, and   
.6.18 mmol/L as high. Triglycerides ,150 mg/dL (,1.7 mmol/L) 
were defined as normal, 150–200 mg/dL (1.7–2.3  mmol/L) as 
increased risk, and .200  mg/dL  (.2.3 mmol/L) as high-risk. 
High-density lipoprotein levels .40 mg/dL (.1.04 mmol/L) 
were taken as normal, 30–40 mg/dL as increased risk, and 
,30 mg/dL as high-risk. Low-density lipoprotein levels 
were optimal if ,100 mg/dL (,1.3 mmol), borderline high 
at 130–159 mg/dL (3.3–4.1 mmol), and high at 160–189 mg/
dL (.4.1 mmol).32–35
All patients were referred to two ophthalmologists work-
ing at the two main hospitals of Al-Madinah Al-Munawarah 
district for a detailed eye examination. After adequate 
mydriasis, examination of the interior segment was carried 
out using a slit lamp with a Volk 90 D lens. Intraocular pres-
sure was measured using a Goldman applanation tonometer. 
Fundus photography was done using a Topcon TRC-NW6 
nonmydriatic fundus camera.
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Diabetic retinopathy was clinically graded in accordance 
with the International Clinical Diabetic Retinopathy guide-
lines as follows: background retinopathy, if microaneurysms, 
hemorrhages (dot, blot, or flame-shaped), hard exudates, 
and/or macular edema was present; proliferative diabetic 
retinopathy, if cotton wool spots, multiple large blot hemor-
rhages, neovascularization of the retina or iris, angle, venous 
beading, loops, and reduplication, arterial sheathing, or an 
atrophic-looking retina were present; and advanced diabetic 
eye disease, if vitreous hemorrhage, retinal detachment, 
rubeosis iridis, or glaucoma was present.36,37
Statistical analysis
Differences were considered statistically significant at 
P , 0.05. SPSS statistical software (v 8; SPSS Inc, Chicago, 
IL) was used to perform the descriptive analysis.
Results
In total, 690 randomly selected diabetic patients were 
included, with a mean age of 46.10 ± 11.85 (range 16–88) 
years. There were 395 males of mean age 46.50 ± 11.31 years 
and 295 females of mean age 45.55 ± 12.53 years. The men 
and women were matched for age, with no statistically signifi-
cant differences (independent t-test, P # 0.295). The patients 
were investigated for gender, type of diabetes   mellitus, smok-
ing status, and family history of hypertension. There were 
more women than men for all variables investigated, except 
for smoking status (Table 1).
The mean duration of diabetes mellitus in all patients 
was 13.35 ± 8.17 years, but was significantly (P # 0.0001) 
shorter in women (11.91 ± 7.92 years) than in men 
(14.42 ± 8.20 years). There was a statistically   significant 
difference (independent-samples test, P # 0.001) between 
women and men for mean BMI (32.00 ± 5.88 and 
33.57 ± 6.86, respectively). Both genders were overweight, 
making them more susceptible to chronic disease, eg, hyper-
tension and diabetes (Table 1).
Men  had  higher  mean  blood  pressure  (systolic 
128.37 ± 19.36 mmHg and diastolic 77.83 ± 10.33 mmHg) 
than women (128.22 ± 21.92 mmHg and 77.93 ± 10.26 mmHg, 
respectively) but the difference was not statistically signifi-
cant. Mean HbA1C was significantly higher (#0.0001) in men 
(8.53 ± 1.81) than in women (7.73 ± 1.84).
One hundred and forty-two (48.13%) of the 295 women 
and 155 (39.24%) of the 395 men had had known diabetes 
for up to 10 years, with 114 (38.64%) women and 139 
(35.18%) men having had the disease for up to 20 years, and 
39 (13.22%) women and 101 (25.56%) men having had it 
for more than 20 years. In total, 297 (43%) had had diabetes 
for up to 10 years, 253 (36.7%) for up to 20 years, and 140 
(20.3%) for more than 20 years (Table 2).
Figure 1 shows the distribution of diabetic retinopathy 
according to grade for all patients in our study. A total of 441 
(63.9%) of 690 patients were free from diabetic retinopathy, 
while 249 (36.1%) had the disorder. Ninety-four (37.7%) of 
the 249 patients had mild nonproliferative diabetic retinopa-
thy (NPDR), representing 13.6% of the total 690 diabetic 
patients in the study. Fifty-four (22%) of the 249 patients 
with diabetic retinopathy had moderate NPDR, representing 
8% of the total 690 diabetic patients. Fifty-six (22.4%) of the 
patients with diabetic retinopathy had severe NPDR, repre-
senting 8.1% of the total 690 patients. Finally, 44 (17.6%) 
of the 249 patients had proliferative diabetic retinopathy, 
representing 6.4% of the total group. Subjects with diabetic 
Table 1 general characteristics of study population and variables according to gender
Variables Women (n = 295) Men (n = 395) Total (n = 690)
Age (mean ± SD) 45.55 ± 12.5 46.50 ± 11.3 46.10 ± 11.8
Type 1 diabetes 27 31 58 (8.4%)
Type 2 diabetes 268 364 632 (91.6%)
Nonsmokers 295 379 674 (97.7%)
Smokers 0 16 16 (2.3%)
Negative family history of hypertension 203 258 461 (66.8%)
Positive family history of hypertension 92 137 229 (33.2%)
Negative family history of diabetes 125 152 277 (40.1%)
Positive family history of diabetes 170 243 413 (59.9%)
Duration of diabetes (mean ± SD) 11.91 ± 7.9 14.42 ± 8.2# 13.35 ± 8.1
Body mass index 32.00 ± 5.8 33.57 ± 6.8* 32.93 ± 6.5
Systolic blood pressure (mmHg) 128.22 ± 21.9 128.37 ± 19.3 128.31 ± 20.5
Diastolic blood pressure (mmHg) 77.93 ± 10.2 77.83 ± 10.3 77.87 ± 10.3
glycated hemoglobin (%) 7.73 ± 1.8 8.53 ± 1.8# 8.41 ± 1.9
Notes: *P # 0.001; #P # 0.0001. 
Abbreviation: SD, standard deviation.
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retinopathy were more likely to be male (155/690, 22.46%) 
than female (94/690, 13.62%). By gender, the proportion of 
patients having diabetic retinopathy was 39.24% for men 
and 31.86% for women (Figure 2).
Diabetes in this study was defined according to self-
reporting of a previous diagnosis of the disease or HbA1C 
$6.5%. Two photographs were taken of the fundus of each 
eye using a digital nonmydriatic camera and were graded 
using the Airlie House classification scheme and the Early 
Treatment Diabetic Retinopathy Study severity scale.
Figure 3 shows fundus images indicating the different 
grades of diabetic retinopathy, ie, a diabetic subject without 
diabetic retinopathy, a case with mild NPDR, a case with 
moderate NPDR, a case with severe NPDR, a case of pro-
liferative diabetic retinopathy, a case of advanced prolifera-
tive diabetic retinopathy and vitreous hemorrhage, a case of 
vitreous hemorrhage with previous laser marks, and a case 
with vitreoretinal traction bands.
Table 3 shows the distribution of patients with diabetic 
retinopathy according to their gender and percentage of the 
frequency in the total population according to classification 
grade of diabetic retinopathy. Two hundred and forty (54.4%) 
of 441 patients free of retinopathy were men, representing 
34.8% of the total study population of 690 patients, and 
201 (45.6%) of the 441 patients free of retinopathy were 
women, representing 29.2% as the total study population. 
Across the different grades of diabetic retinopathy, the fre-
quency for men was proportionally greater than for women.
Table 4 shows the distribution of patients according to 
gender and frequency in the total population and grading of 
diabetic retinopathy and duration of diabetes. Diabetic patients 
free from retinopathy with a disease duration of less than 
10 years comprised 208 of 262 patients, and patients with mild 
NPDR comprised 51 patients (19.46%); another three were 
found under the moderate grade and nothing was recorded for 
severe NPDR or proliferative diabetic retinopathy.   Therefore, 
about 20% of the patients developed retinopathy within 
ten years of being diagnosed as having diabetes mellitus. 
This strongly suggests that screening of diabetic patients 
for the presence of retinopathy should not be delayed until 
they have suffered from the disease for 10 years, and should 
commence sooner. We also noticed from the results that the 
longer the patients had had diabetes, the greater the likelihood 
of them having advanced grades of diabetic retinopathy, with 
75% of patients with severe NPDR and proliferative diabetic 
retinopathy having had diabetes for more than 30 years and 
87.5% of those with proliferative diabetic retinopathy hav-
ing had diabetes for more than 40 years. There were positive 
Table 2 Duration of diabetes in men and women according to type of diabetes
Duration of  
diabetes (years)
Men Women Total
Type 1 Type 2 Total Type 1 Type 2 Total
,10 2 153 155 0 142 142 297 (43%)
11–20 19 120 139 12 102 114 253 (36.7%)
.20 10 91 101 15 24 39 140 (20.3%)
Total 31 364 395 27 268 295 690
441
63.9 %
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13.6% 55
8%
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8.1%
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6.4%
0
50
100
150
200
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300
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400
450
500
Normal Mild NPDR Moderate NPDR Sever NPDR PDR
Figure 1 Distribution of diabetic patients according to retinopathy grade. The white 
cylinder represents diabetic patients with a normal retina, the black cylinder shows 
mild NPDR, the check board cylinder shows moderate NPDR, the cylinder with 
vertical lines shows severe NPDR, and the cylinder with horizontal lines shows PDR. 
Abbreviations: PDR, proliferative diabetic retinopathy; NPDR, nonproliferative 
diabetic retinopathy.
40
39.24%
31.86%
22.46%
13.62%
35
30
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20
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10
5
0
DR out of the same gender DR out of the total
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Figure 2 Diabetic retinopathy in all diabetic patients according to gender. The 
white cylinder represents female diabetic patients and males are represented by 
the black cylinder. 
Abbreviation: DR, diabetic retinopathy.
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significant correlations between the duration of diabetes 
  mellitus, HbA1c, and grades of diabetic retinopathy (R2 0.835 
and 0.796, respectively, Figures 4 and 5).
Discussion
The International Diabetes Federation in 2003 ranked the 
Kingdom of Saudi Arabia prevalence rates for type 2 diabetes 
mellitus and impaired glucose tolerance as the second highest 
in the world (20% and 26%, respectively)3 indicating that 
the disease and its complications, such as retinopathy, might 
constitute a sizable health care burden to the population. 
Despite that, little is known about the true impact of diabetes 
and its complications, including diabetic retinopathy, in the 
population of the Kingdom of Saudi Arabia.
Retinopathy was present in 34.6% of our study popula-
tion. It was suggested in 1998 that 20% of diabetics world-
wide will develop diabetic retinopathy,38 which is similar to 
the rate recorded in Al-Ain, United Arab Emirates (19%), 
but is clearly lower than that reported in other populations 
such as the US (40%–45%),13 Saudi Arabia (31%),17 the 
Sultanate of Oman (42%),39 and Egypt (42%).40 However, it 
is substantially higher than the 8% rate reported in a similar 
study in Kuwait,41 11.6% in Saudi Arabia during 2002,42 
and 16.9% in China.43 Studies in Ethiopia, France, and 
Japan have demonstrated higher rates.44–46 The substantial 
Without DR Early diabetic retinopathy Mild NPDR
Moderate NPDR Severe NPDR PDR and neovascularization
PDR with vitreous hemorrhage PDR with vitreous hemorrhage
and PLM
Vitreoretinal traction bands
Figure 3 Fundus images of normal (background retinopathy), mild NPDR, moderate NPDR, severe NPDR, PDR, PDR with new vascularization, and PDR with PLM and with 
vitreous hemorrhage. 
Abbreviations: PDR, proliferative diabetic retinopathy; NPDR, nonproliferative diabetic retinopathy; PLM, previous laser marks.
Table 3 Diabetic retinopathy grade in diabetic patients according 
to gender
Diabetic  
retinopathy grades
Males Females
n % of  
grade
% of  
total
n % of  
grade
% of  
total
Normal 240 54.4 34.8 201 45.6 29.2
Mild NPDR 57 60.6 8.3 37 39.4 5.4
Moderate NPDR 30 54.5 4.3 25 45.5 3.6
Severe NPDR 33 58.9 4.8 23 41.1 3.3
PDR 35 79.5 5.1 9 20.5 1.3
Abbreviations: PDR, proliferative diabetic retinopathy; NPDR, nonproliferative 
diabetic retinopathy.
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heterogeneity in reported prevalence of retinopathy may be 
real to some extent. This may be due to differences in the age 
distribution of different populations, but may also be due to 
differences in study methodology and population sampling. 
The large number of late diabetic cases recorded in our study 
could have led to a relatively high prevalence rate.
As demonstrated elsewhere, our findings clearly show that 
diabetic retinopathy is a common health problem and may 
well be among the leading causes of blindness in Saudi adults. 
It is well established that nearly all patients with type 1 and 
type 2 diabetes are at increasing high risk for the disease.2,16
The fact that the majority of our study population (63%) 
was not well educated further emphasizes the seriousness and 
complexity of the diabetes problem in the Kingdom of Saudi 
Arabia. Therefore, heightened awareness of the importance of 
a comprehensive annual eye examination with pupil dilation in 
illiterate patients is necessary. Clinicians treating these patients 
should also be reminded to follow the treatment guidelines for 
diabetes closely and refer all diabetics to an ophthalmologist for 
management and treatment as indicated to preserve vision.
Analysis of our study population shows that diabetic 
retinopathy increases with patient age and disease dura-
tion; this positive association between diabetic retinopathy 
and duration of diabetes is noted in the literature.8,9,14,15,18 
For example, the reported rate of retinopathy in southern 
India46 and in the Sultanate of Oman47 was 7% in individu-
als with a short duration of diabetes (less than 10 years), 
26% in those with disease of 10–14 years’ duration, and 
63% in those with a diabetes duration of 15 years, and 
these observations close match those of our study. Duration 
of diabetes is known to reflect total glycemic control and 
risk factor exposure over time.2,18 While this may suggest 
avenues for primary prevention, the true prospects for that 
are currently unknown.
In a longitudinal study, Wang et al16 showed that nearly 
all type 1 diabetics and approximately two-thirds of type 
2 diabetics develop retinopathy after a disease duration of 
20 years, regardless of their diabetic control. However, their 
analysis revealed that diabetic retinopathy in the study sample 
was only marginally associated with hypertension, which is 
widely regarded as a significant risk factor for diabetic retin-
opathy in most studies.10,19 Improved monitoring and control 
of hypertension among diabetic patients in the United Arab 
Emirates, which has been shown to slow the progression of 
retinopathy, particularly among those with poorly controlled 
diabetes, is strongly recommended.20
Table 4 Diabetic retinopathy grades according to duration of diabetes
Diabetes  
duration (years)
Normal Mild NPDR Moderate  
NPDR
Severe  
NPDR
PDR Total
n % n % n % n % n % n %
,10 208 79.38 51 19.46 3 1.14 0 0 0 0 262 37.97
,20 140 52.83 32 12.07 47 17.73 35 13.20 11 4.15 265 38.41
,30 93 68.88 7 5.18 3 2.22 14 10.37 18 13.33 135 19.56
,40 0 0 3 15 2 10 7 35 8 40 20 2.90
.40 0 0 1 12.5 0 0 0 0 7 87.5 8 1.16
Total 441 63.91 94 13.62 55 7.97 56 8.11 44 6.37 690 100
Abbreviations: PDR, proliferative diabetic retinopathy; NPDR, nonproliferative diabetic retinopathy.
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Figure 4 Correlation between diabetic retinopathy grades according to duration of diabetes. 
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Our results showing a significant positive association 
between HbA1C levels and different grades of diabetic 
  retinopathy are consistent with other reports.12–16 HbA1C lev-
els in diabetic Saudi patients were more than 8%, and there 
was a positive correlation between diabetic retinopathy and 
hyperlipidemia. It is strongly recommended that glycemic 
and lipidemic control be widely promoted and that HbA1C 
and lipid profile investigations be carried out routinely.
In Saudi Arabia, women had significantly higher rates of dia-
betic retinopathy than men, which is in agreement with a study 
in Sweden where women had higher rates than men49 and in 
other studies.13,19Two further studies have suggested nonsignifi-
cant differences in diabetic retinopathy according to gender.50,51 
However, our results are in contrast with results from Oman.48 
Smoking was associated with an increased likelihood of having 
diabetic retinopathy, as reported in other studies.17,18,39–41
Our study results are consistent with those in neighboring 
countries, such as the Sultanate of Oman48 and the United 
Arab Emirates,52 where the prevalence of retinopathy was also 
higher in patients with diabetes and its complications such as 
coronary artery disease, peripheral neuropathy, and vascular 
disease,22,23 such as hypertension.12,13 Surprisingly, and unlike 
findings elsewhere,53 the degree of glycemic control did not 
show any significant association with diabetic retinopathy 
in the study sample.
Our study has some limitations. First, the assumption that 
diabetic patients with blindness and cataract had diabetic 
retinopathy as the primary cause may have led to some slight 
overestimation of the prevalence of retinopathy. Second, it 
is known that diabetes is notoriously underdiagnosed; there-
fore, while our sample probably reflects diabetic retinopathy 
among diagnosed diabetic patients adequately, it is likely that 
this proportion still represents only the tip of the iceberg.
Conclusion
The prevalence of diabetic retinopathy in Al-Madinah 
Al-Munawarah, Kingdom of Saudi Arabia, was 36.1%. 
Based on the findings of the current study, it is strongly 
recommended to perform regular screening for diabetic 
retinopathy, thereby increasing the chances of preventing a lot 
of diabetes-related blindness. Long duration since diagnosis 
of diabetes, hypertension, high HbA1C levels, advancing 
age, and male gender are associated with advanced stages 
of diabetic retinopathy.
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